'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges

'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges
Image credit: Getty Images
Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals.

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!
1 min read
This story originally appeared on Fortune Magazine

Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals, has been arrested on suspicion of securities fraud, according to Bloomberg News.

Shkreli, 32, became infamous earlier this year when he drastically raised the price of a drug taken by AIDS patients, but Bloomberg said the case against him is unrelated to that.

Instead, prosecutors have charged him with illegally taking stock from Retrophin Inc., a biotech firm which he founded in 2011, and using it to pay off unrelated business debts, Bloomberg said.

Shkreli’s hedge fund MSMB Capital Management suffered heavy losses as a result of the fraud, the agency added, referring also to allegations of “secret payoffs” and “sham consulting arrangements.”

More from Entrepreneur

We created the Start Your Own Business (SYOB) course to help you get started on your entrepreneurial journey. You will learn everything you need to know about testing the viability of your idea, writing a business plan, raising funds, and opening for business.
Jumpstart Your Business. Entrepreneur Insider is your all-access pass to the skills, experts, and network you need to get your business off the ground—or take it to the next level.
Let us help you take the NEXT step. Whether you have one-time projects, recurring work, or part-time contractors, we can assemble the experts you need to grow your company.

Latest on Entrepreneur